Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
Explore this paper's citation graph
Summary
The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.
- Type
- article
- Published
- 1991-08-01
- Cited by
- 7,904
- References
- 7
- Access
- Open access
- OpenAlex
- https://openalex.org/W2585382523
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:38574853
Keywords
Enalapril, Heart failure, Medicine, Cardiology, Internal medicine
References
- Effect of drug therapy on survival in chronic congestive heart failure.
- Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
- Changes in Hypertension Treatment and in Congestive Heart Failure Mortality in the United States
- Immediate and Sustained Hemodynamic and Clinical Improvement in Chronic Heart Failure by an Oral Angiotensin‐converting Enzyme Inhibitor
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
- The natural history of congestive heart failure: the Framingham study.
- Nonparametric Estimation from Incomplete Observations
- Discrete Sequential Boundaries for Clinical Trials
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.
Cited by
- Vascular renin-angiotensin-system, endothelial function and atherosclerosis?
- Pharmacological Prevention of Reperfusion Injury in Acute Myocardial Infarction
- Inotropic therapy for heart failure--an unfulfilled promise.
- Prävention des linksventrikulären Remodelings
- A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.
- 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
- ACE inhibitors in heart failure. What dose?
- “Escape” of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy
- Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure.
- Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators.
- Current and ongoing randomized trials in heart failure and left ventricular dysfunction.
- Efficacy and dosage of enalapril in congenital and acquired heart disease.
- Angiotensin-converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens.
- Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. The IMPROVE Study Group.
- What is the Role of Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure and after Myocardial Infarction?
- Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure.
- Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction.
- Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease
- Differences in generalist and specialist physicians’ knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure
- Effect of ramipril on mitral regurgitation secondary to mitral valve prolapse.
Related papers
- Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction.
- Evaluation of ACE Inhibitor Therapy for Congestive Heart Failure in an Outpatient Setting
- Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
- Role of converting enzyme inhibitors in the treatment of heart failure.
- Neurohormonal mechanisms and the role of angiotensin-converting enzyme (ACE) inhibitors in heart failure
- Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
- Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction.
- Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure.